Summary and Compliance of EOI
Summary and Compliance of EOI
Summary and Compliance of EOI
Vision
Prepare national statistics of international standards.
Mission
Statistics are prepared in a modern manner for the development and public welfare of the
country and analyzed, stored and published through advanced information technology.
About GTCBL:
Grant Thornton Consulting Bangladesh Limited (GTCBL) a full member firm of Grant Thornton
International, one of the world’s leading professional services firms with over 58,000 Grant Thornton
People, across 138 countries, focused on making a difference to clients, colleagues and the
communities in which we live and work.
Grant Thornton Consulting enjoys a position of leadership in its areas of expertise based on
formidable credentials, dynamism and superior quality of qualified and diverse human
resources.
We provide services, principally in areas of transaction advisory, corporate finance, strategy
and growth, structured finance, restructuring, governance risk and compliance, social policy,
human resource management, organizational development and technology solutions.
We work closely with other Grant Thornton practices in the region to provide global reach
with local know-how.
All services are provided in strict accordance with the international quality standards set out
by Grant Thornton International.
A list of relevant health projects is given below:
Non-Consulting Services (SD-28): COVID-19 Awareness and Trainings (Lot 2: Online
Training for Doctors)
Biennial Fiduciary (Financial, Procurement, Governance, Service Delivery) Reviews for the
Urban Primary Health Care Services Delivery Project-Additional Financing (Loan 3705) for
FY2018- FY2019, FY2019-FY2020, and FY2020-FY2021.
Sinovac Biotech (Bangladesh) Ltd.
ESCO Lifesciences Bangladesh Pvt. Ltd.
Conducting physical inventory (of current stock) and commodity audit of FY 2018-19”
(Package No: PSSM/SD-02 and Proposals No: DGFP/L&S- 2/Commodity Audit/2019-
20/109/2020/1961)”
Ref.
Particulars
No.
A) Experience, Resources and Delivery Capacity Required
a) Must have significant knowledge about thalassemia disease and at least 15 years of work
experience in diagnosing or preventing thalassemia diseases.
ADSL have 24 years’ experience and JV member Dr. Lal PathLabs Bangladesh Ltd have 12
years’ experience knowledge about thalassemia disease and have work experience in
diagnosing or preventing thalassemia diseases.
b) Must have a dedicated diagnostic lab to screen and test the blood samples to identify the
prevalent thalassemia blood.
Dr. Lal PathLabs Bangladesh has a dedicated diagnostic lab to screen and test the blood
samples to identify the prevalent thalassemia blood across 64 districts through B2B and B2C
partners.
c) The diagnostic lab must have the necessary approval from the competent authority of the
government.
Dr. Lal PathLabs has the necessary approval from the competent authority of the government.
License No: HSM4510304
Reg. Code: HSM46743
Approved Year: 2023-2024 [Renewal]
Expiry Date: 30 June 2024
d) The lab should have enough facilities to diagnose thalassemia with more than 300 daily
samples for the proposed survey.
Dr. Lal PathLabs Bangladesh has more than enough facilities to diagnose thalassemia with
more than 300 daily samples for the proposed survey through our B2B and B2C partners.
i) Should have valid registration from respective government authority/valid Trade License,
VAT, and TIN Registration and audit report for the last 03 (three) years (where
applicable).
Lead Firm ASDL and JV Member GTCBL and Dr. LalPath Labs Bangladesh have valid
registration from respective government authority/valid Trade License, VAT, and TIN
Registration and audit report for the last 03 (three) years. We have incorporated it in this EOI
documents.
j) Joint Venture (JV) firms can also apply with the original copy of the JV agreement.
Original JV Agreement worth 300 BDT non-judicial stamp prepared by Joint Venture (JV)
firms and accordingly signed by JV members and have been incorporated in EOI documents.
In Addition,
PRITI Research & Consultancy Limited have been added as Sub-Consultant. PRITI has vast experience has survey field.
PRITI Research & Consultancy Limited is a Market, Social & Business Research & Consultancy Company situated at
Kazipara, Mirpur in Dhaka-1216, Bangladesh. PRITI is the abbreviation of Participatory Research & Innovative
Technical Initiatives. PRITI is a result of combined efforts where young energetic, highly experienced and national
leading sector specialists are engaged. PRITI follows the “PARTICIPATORY METHODS” for conducting all types of
research works where both parties (PRITI Research & Consultancy Limited and Clients) work together for data
reliability, validity, authenticity & overall better results. PRITI has several types of research products & consulting
service items for corporate house, product manufacturers, importers, traders, and distributors as well as the service
base companies such as National & International NGOs, Donor Agencies, Development Partners, International aids,
Govt. Agencies and many more. PRITI believes that any types of research findings can change your vision/future.
Our Understanding of Assignment/Scope of Services:
Blood sample collection from general households was selected through appropriate sampling
methods, transportation of collected blood samples, preservation, and laboratory testing to
generate clinical information regarding both thalassemia and hepatitis B. The firm should
produce computer-generated (prescribed tabular format) reports, data management, data
processing, and data analysis for the national thalassemia survey:
a) Collect blood samples from different parts of the country through competent and
experienced medical technologists and blood picker assistants;
b) Guidelines to be prepared for the medical technologist for the collection, preservation,
and safe transportation of blood.
c) Transport safely the collected blood samples to a laboratory for testing thalassemia
prevalence and hepatitis B from different parts of the country (as per selected sample
areas).
d) Preserve the collected blood samples appropriately safely and securely.